Blood filtering for acute pancreatitis
Part of Digestive system clinical trials.
This trial tests whether a special blood filter (Efferon LPS) can help people with moderate to severe acute pancreatitis by removing harmful substances. It is for those who have been sick for 5 days or less and have certain signs of inflammation or organ stress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute pancreatitis within the last 5 days
- Your pancreatitis is moderate or severe according to the Atlanta classification
- You have a CT scan showing a severity score of 4 or higher
- Your APACHE II score is more than 8
- You have at least 2 points on the SOFA scale or at least 2 signs of systemic inflammation (fever, fast heart rate, fast breathing, or abnormal white blood cell count)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage hospital study tests whether pirfenidone is safe and tolerable for people with acute pancreatitis that may become severe. It may help by reducing the risk of complications, while researchers carefully track side effects.
This trial tests whether using blood “filters” plus high-volume fluid filtration can improve outcomes in adults with acute pancreatitis without infection. It aims to remove inflammatory substances from the blood early, while ensuring you’re stable enough for several hours of treatment.
This trial is testing a device that filters your blood to remove inflammatory particles (cfDNA and NETs) that may be worsening organ damage from pancreatitis. It is for people who have developed breathing, heart, or kidney problems while hospitalized with pancreatitis.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This trial tests a special blood-filtering device (Efferon LPS) used during heart surgery to reduce inflammation and improve recovery. The device removes harmful substances from your blood during the operation.
Hear when a new Pancreatitis, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.